Graves병 관해의 예측 지표

참고문헌 (46)

1. De Groot L.J, "The cause of autoimmune thyroid disease.", Endocr Rev, 10, pp.537~562 (1989)
2. Smith B.R, "Autoantibodies to the thyrotropin receptor.", Endocr Rev, 9, pp.106~121 (1988)
3. Jonas M, "Predicting a relapse of Graves' hyperthyroidism in adults during the early phase of treatment with anti- thyroid drugs.", Endokrynol Pol, 57, pp.596~604 (2006)
4. Schott M, "Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.", Horm Metab Res, 39, pp.56~61 (2007)
5. Yamada T, "Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease.", Endocrinol J, 53, pp.783~788 (2006)
6. Wille T, "Long- term follow up after antithyroid drug treatment in Graves' disease.", Schweiz Rundsch Med Prax, 95, pp.1121~1127 (2006)
7. Jaruratanasirikul S, "Thyrotoxicosis in children: treatment and outcome.", J Med Assoc Thai, 89, pp.967~973 (2006)
8. Okamoto Y, "TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs.", Endocr J, 53, pp.467~472 (2006)
9. Schott M, "Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.", Horm Metab Res, 37, pp.741~744 (2005)
10. Barrio R, "Graves' disease in children and adolescents: response to long-term treatment.", Acta Paediatr, 94, pp.1583~1589 (2005)
11. Quadbeck B, "Basedow Study Group. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.", Thyroid, 15, pp.1047~1054 (2005)
12. Izumi Y, "Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.", Endocr J, 52, pp.493~497 (2005)
13. Saleh A, "Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.", Exp Clin Endocrinol Diab, 112, pp.510~513 (2004)
14. Schott M, "Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.", Horm Metab Res, 36, pp.92~96 (2004)
15. Kashiwai T, "Practical treatment with minimum maintenance dose of anti-thyroid drugs for prediction of remission in Graves' disease.", Endocrinol J, 50, pp.45~49 (2003)
16. Tada H, "Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.", Clin Endocrinol (Oxf), 58, pp.403~408 (2003)
17. Orgiazzi J, "Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease.", Thyroid, 12, pp.849~853 (2002)
18. Bolanos F, "Remission of Graves' hyperthyroidism treated with methimazole.", Rev Invest Clin, 54, pp.307~310 (2002)
19. Wallaschofski H, "Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.", Horm Metab Res, 34, pp.383~388 (2002)
20. Komiya I, "Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.", J Clin Endocrinol Metab, 86, pp.3540~3544 (2001)
21. Takasu N, "Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.", Thyroid, 10, pp.891~896 (2000)
22. Allahabadia A, "Age and gender predict the outcome of treatment for Graves' hyperthyroidism.", J Clin Endocrinol Metab, 85, pp.1038~1042 (2000)
23. Raber W, "Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.", Eur J Endocrinol, 142, pp.117~124 (2000)
24. Mussa G.C, "Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years.", J Pediatr Endocrinol Metab, 12, pp.537~541 (1999)
25. Zouvanis M, "Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.", J Endocrinol Invest, 21, pp.771~774 (1998)
26. Benker G, "Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.", Clin Endocrinol (Oxf), 49, pp.451~457 (1998)
27. Pujol P, "TSH suppression combined with carbimazole for Graves' disease: effect on remission and relapse rates.", Clin Endocrinol (Oxf), 48, pp.635~640 (1998)
28. Michelangeli V, "The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs.", Thyroid, 8, pp.119~124 (1998)
29. Vitti P, "Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.", Thyroid, 7, pp.369~375 (1997)
30. Glaser N.S, "Predictors of early remission of hyperthyroidism in children.", J Clin Endocrinol Metab, 82, pp.1719~1726 (1997)
31. Heshmati H.M, "Prognostic value of suppressed thyrotropin level and positive thyrotropin- receptor antibody activity in Graves' disease with long-lasting clinical remission.", Endocr Pract, 3, pp.113~117 (1997)
32. Benker G, "Response to methimazole in Graves' disease.", Clin Endocrinol, 43, pp.257~263 (1995)
33. Takasu I, "Simple and reliable method for predicting the Graves' disease; Revised triiodothyronine suppression test, indexed by serum thyroxine.", J Endocrinol Invest, 18, pp.288~294 (1995)
34. Cho B.Y, "Evaluation of serum basal thyrotropin levels and thyrotopin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.", Clin Endocrinol, 36, pp.585~590 (1992)
35. Schleusener H, "Prospective multicenter study on prediction of relapse after antithyroid drug treatment in patients with Graves' disease.", Acta Endocrinol, 120, pp.689~701 (1989)
36. Young E.T, "Prediction of remission after antithyroid drug treatment in Graves' disease.", Q J Med, 66, pp.175~189 (1988)
37. 조보연, "임상갑상선학.", pp.279~342 (2005)
38. 대한소아내분비학회, "소아내분비학.", pp.136~142 (2004), 광문출판사
39. DeGroot L.J, "Endocrinology.", pp.1995~2028 (2006)
40. 김호성, "소아 갑상선 기능 항진증의 치료.", 소아내분비, 4, pp.10~13 (1999)
41. Collen R.J, "Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs.", Pediatrics, 65, pp.550~556 (1980)
42. Lippe B.M, "Hyperthyroidism in children treated with long term medical therapy; twenty-five percent remission every two years.", J Clin Encocrinol Metab, 64, pp.1241~1245 (1987)
43. Glaser N.S, "Predictors of early remission of hyperthyroidism in children.", J Clin Endocrinol Metab, 82, pp.1719~1726 (1997)
44. Shulman D.I, "Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy.", Thyroid, 7, pp.755~760 (1997)
45. Lazar L, "Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients.", J Clin Endocrinol Metab, 85, pp.3678~3682 (2000)
46. Rivkees S.A, "An optimal treatment for pediatric Graves' disease is radioiodine.", J Clin Endocrinol Metab, 92, pp.797~800 (2007)

관련 논문AI추천